Literature DB >> 23202265

What is the price of prevention? New evidence from a field experiment.

Edward N Okeke1, Clement A Adepiti, Kayode O Ajenifuja.   

Abstract

How does increasing access to treatment affect the demand for preventive testing? In this paper we present results from a field experiment in Nigeria in which we offered cervical cancer screening to women at randomly chosen prices. To test our hypothesis, we also offered women a lottery where the payoff was a subsidy towards the cost of cervical cancer treatment (conditional upon a diagnosis of cervical cancer). We find that women randomly selected to receive the conditional cancer treatment subsidy were about 4 percentage points more likely to take up screening than those in the control group. We also show that reducing the price of screening by 10 cents increased take-up by about 1 percentage point. These results offer compelling evidence that the optimal set of subsidies to increase take-up of preventive testing in developing countries, must include subsidies towards treatment costs (in addition to price subsidies).
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23202265     DOI: 10.1016/j.jhealeco.2012.10.001

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  6 in total

1.  Learning from Others' HIV Testing: Updating Beliefs and Responding to Risk.

Authors:  Susan Godlonton; Rebecca L Thornton
Journal:  Am Econ Rev       Date:  2013-05

Review 2.  Interventions targeted at women to encourage the uptake of cervical screening.

Authors:  Helen Staley; Aslam Shiraz; Norman Shreeve; Andrew Bryant; Pierre Pl Martin-Hirsch; Ketankumar Gajjar
Journal:  Cochrane Database Syst Rev       Date:  2021-09-06

3.  Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review.

Authors:  Lauren G Johnson; Allison Armstrong; Caroline M Joyce; Anne M Teitelman; Alison M Buttenheim
Journal:  Implement Sci       Date:  2018-02-09       Impact factor: 7.327

4.  Assessing the independent and combined effects of subsidies for antimalarials and rapid diagnostic testing on fever management decisions in the retail sector: results from a factorial randomised trial in western Kenya.

Authors:  Wendy Prudhomme O'Meara; Manoj Mohanan; Jeremiah Laktabai; Adriane Lesser; Alyssa Platt; Elisa Maffioli; Elizabeth L Turner; Diana Menya
Journal:  BMJ Glob Health       Date:  2016-09-28

Review 5.  Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model.

Authors:  Breanne E Lott; Mario J Trejo; Christina Baum; D Jean McClelland; Prajakta Adsul; Purnima Madhivanan; Scott Carvajal; Kacey Ernst; John Ehiri
Journal:  BMC Public Health       Date:  2020-05-11       Impact factor: 3.295

Review 6.  A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence.

Authors:  Helen I Anyasi; Anna M Foss
Journal:  Int Health       Date:  2021-07-03       Impact factor: 2.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.